Estimated Vaccination Coverage^ with Individual Vaccines and Vaccination Series Among Children 19-35 Months of Age by Race/Ethnicity* -- US, National Immunization Survey, Q1/2010-Q4/2010†

Vaccine		US National	White only, non-Hispanic	Black only, non-Hispanic	Hispanic	American Indian or Alaska Native only, non-Hispanic	Asian only, non-Hispanic	Native Hawaiian or Other Pacific Islander only, non-Hispanic	Multiple Race, non-Hispanic
3+DTaP¥		95.0±0.6	95.1±0.8	95.3±1.5	95.1±1.4	97.3±2.2	95.7±2.9	96.9±3.5	92.4±3.5
4+DTaP‡		84.4±1.0	84.5±1.3	83.7±2.7	84.4±2.5	81.8±7.5	88.3±4.0	NA	82.8±4.8
3+Polio§		93.3±0.7	93.2±0.8	94.0±1.6	93.8±1.6	94.6±3.5	92.8±3.5	95.1±4.5	90.2±3.9
1+MMRll		91.5±0.7	90.6±0.9	92.1±1.9	92.9±1.6	93.4±6.3	91.7±3.6	96.9±4.0	89.7±3.8
3+Hib¶		90.4±0.9	90.3±1.2	89.4±2.3	92.0±1.7	93.9±3.0	85.7±5.7	93.1±6.4	87.3±4.4
Hib-PS**		92.2±0.8	92.3±1.1	90.9±2.2	93.3±1.5	95.7±2.7	89.0±5.3	94.4±5.8	90.4±3.8
Hib-FS††		66.8±1.3	67.5±1.6	65.4±3.4	64.8±3.1	77.1±7.4	69.5±6.8	NA	70.1±5.8
3+HepB‡‡		91.8±0.7	91.4±0.9	92.1±1.8	92.5±1.7	97.2±2.3	91.7±3.5	96.7±3.6	89.9±3.8
Hep B Birth dose§§		64.1±1.3	63.2±1.6	64.1±3.6	65.5±3.1	71.9±9.6	62.6±7.2	NA	64.4±6.4
1+Varllll		90.4±0.8	88.9±1.1	91.5±2.0	92.3±1.8	95.7±2.7	92.5±3.4	92.7±6.8	88.9±3.9
3+PCV¶¶		92.6±0.8	92.8±0.9	92.6±2.0	93.4±1.8	94.5±3.0	87.8±5.4	96.7±3.5	90.6±3.8
4+PCV***		83.3±1.0	84.2±1.2	79.7±3.0	83.9±2.3	85.3±5.0	78.9±6.0	NA	83.0±4.7
2+HepA†††		49.7±1.4	45.8±1.6	48.6±3.7	57.0±3.1	NA	50.8±7.5	NA	49.8±6.6
Rotavirus‡‡‡		59.2±1.4	60.2±1.7	52.7±3.6	60.5±3.2	NA	62.6±7.0	NA	57.7±6.5
4:3:1§§§		82.0±1.1	81.5±1.3	81.8±2.8	82.8±2.5	81.1±7.5	85.2±4.4	NA	81.2±4.9
4:3:1:3llllll		78.8±1.2	78.2±1.5	78.0±3.0	80.4±2.6	79.6±7.6	77.6±6.1	NA	78.4±5.1
4:3:1:3-PS¶¶¶		80.3±1.1	79.8±1.5	79.3±3.0	81.6±2.6	80.2±7.6	80.2±5.9	NA	80.3±5.0
4:3:1:4-FS****		62.2±1.3	62.5±1.6	61.0±3.5	61.0±3.2	69.8±8.9	65.4±7.0	NA	65.6±6.1
4:3:1:3:3:1€		74.9±1.2	73.6±1.5	74.5±3.1	77.2±2.7	77.2±7.8	74.4±6.3	NA	75.8±5.3
4:3:1:0:3:1ς		77.8±1.1	76.7±1.4	77.4±3.0	79.4±2.7	78.7±7.7	81.4±4.8	NA	78.4±5.1
4:3:1:3:3:1-PS€€		76.3±1.2	75.0±1.5	75.7±3.1	78.3±2.7	77.8±7.8	76.9±6.0	NA	77.7±5.1
4:3:1:4:3:1-FSςς		59.2±1.3	59.0±1.6	58.3±3.6	58.3±3.2	67.4±9.0	62.9±7.1	NA	63.1±6.1
4:3:1:3:3:1:4€€€		70.2±1.3	69.9±1.6	66.9±3.4	72.0±2.9	73.1±8.1	67.3±6.7	NA	73.0±5.4
4:3:1:0:3:1:4ςςς		72.7±1.2	72.7±1.5	69.3±3.4	74.1±2.8	74.5±8.1	70.2±6.5	NA	75.6±5.2
4:3:1:3:3:1:4-PS€€€€		71.5±1.2	71.2±1.6	68.1±3.4	73.2±2.8	73.7±8.1	69.8±6.5	NA	74.9±5.2
4:3:1:4:3:1:4-FSςςςς		56.6±1.3	56.9±1.6	54.5±3.6	55.5±3.2	64.1±9.2	59.3±7.2	NA	61.3±6.2

---

^ Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.588 or (CI half width) >10.

Estimates presented as point estimate (%) ± 95% Confidence Interval.

* Self-reported by respondent. Children of Hispanic ethnicity may be of any race.

† Children in the Q1/2010-Q4/2010 National Immunization Survey were born from January 2007 through July 2009.

¥ 3 or more doses of any diphtheria and tetanus toxoids and pertussis vaccines including diphtheria and tetanus toxoids, and any acellular pertussis vaccine (DTaP/DTP/DT).

‡ 4 or more doses of DTaP.

§ 3 or more doses of any poliovirus vaccine.

ll 1 or more doses of measles-mumps-rubella vaccine.

¶ 3 or more doses of Haemophilus influenzae type b (Hib) vaccine.

** Primary series Hib: ≥2 or ≥3 doses of Haemophilus influenzae type b (Hib), depending on brand type.

†† Full series Hib: ≥3 or ≥4 doses of Hib vaccine depending on product type received (includes primary series plus the booster dose).

‡‡ 3 or more doses of hepatitis B vaccine.

§§ 1 or more doses of hepatitis B vaccine administered between birth and age 3 days.

llll 1 or more doses of varicella at or after child's first birthday, unadjusted for history of varicella illness.

¶¶ 3 or more doses of pneumococcal conjugate vaccine (PCV).

*** 4 or more doses of PCV.

††† 2 or more doses of Hepatitis A vaccine.

‡‡‡ ≥2 or ≥3 doses of Rotavirus vaccine, depending on product type received ( ≥2 doses for Rotarix® [RVI] or ≥3 doses for RotaTeq® [RV5]).

§§§ 4 or more doses of DTaP, 3 or more doses of poliovirus vaccine, and 1 or more doses of any MMR vaccine.

llllll 4:3:1 plus 3 or more doses of Hib vaccine of any type.

¶¶¶ 4:3:1 plus the primary series Hib.

**** 4:3:1 plus the full series Hib.

€ 4:3:1 plus 3 or more doses of Hib vaccine of any type, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.

ς 4:3:1 plus 3 or more doses of HepB vaccine and 1 or more doses of varicella vaccine. Hib vaccine is excluded.

€€ 4:3:1 plus primary series of Hib vaccine, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.

ςς 4:3:1 plus full series of Hib vaccine, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.

€€€ 4:3:1 plus ≥3 doses of Hib vaccine of any type, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.

ςςς 4:3:1 plus 3 or more doses of HepB vaccine, 1 or more doses of varicella vaccine, and 4 or more doses of PCV. Hib vaccine is excluded.

€€€€ 4:3:1 plus primary series Hib vaccine, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.

ςςςς 4:3:1 plus full series Hib vaccine, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.

tab45_race_nat